
Sergio Cifuentes Canaval
Jul 27, 2025, 21:59
Sergio Cifuentes Canaval: Expanding Treatment Options for Patients with BRAF V600E-Mutated mCRC
Sergio Cifuentes Canaval, Medical Oncologist, ASCO International Development and Education Award (IDEA) Recipient – 2025 at Conquer Cancer, the ASCO Foundation, shared a post on X:
“New arrival of ENCORA + CETUXIMAB in Colombia.
A step forward in expanding treatment options for patients with BRAF V600E-mutated mCRC. Looking forward to its approval in 1L soon.”
More posts on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 28, 2025, 03:49
Jul 27, 2025, 20:55
Jul 27, 2025, 19:47
Jul 27, 2025, 17:59